Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ameliorative impacts of polymeric and metallic nanoparticles on cisplatin-induced nephrotoxicity: a 2011–2022 review
Maryam Davoudi, Yasaman Jadidi, Kiana Moayedi, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 17

Showing 17 citing articles:

Inhibition of Gpx4-mediated ferroptosis alleviates cisplatin-induced hearing loss in C57BL/6 mice
Ziyi Liu, Hanbing Zhang, Guodong Hong, et al.
Molecular Therapy (2024) Vol. 32, Iss. 5, pp. 1387-1406
Closed Access | Times Cited: 24
Complications and comorbidities associated with antineoplastic chemotherapy: Rethinking drug design and delivery for anticancer therapy
Xiaoman Mao, Shuang Wu, Dandan Huang, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 7, pp. 2901-2926
Open Access | Times Cited: 9
Oxidative Damage as a Fundament of Systemic Toxicities Induced by Cisplatin—The Crucial Limitation or Potential Therapeutic Target?
Jelena Katanić, Dragica Selaković, Gvozden Rosić
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14574-14574
Open Access | Times Cited: 20
Drug delivery for platinum therapeutics
Hui Liu, Jiahui Zou, Xiaotong Li, et al.
Journal of Controlled Release (2025) Vol. 380, pp. 503-523
Closed Access
Cisplatin-induced Disruption of Mitochondrial Divisome Leads to Enhanced Cisplatin Resistance in Cholangiocarcinoma
Guoyue Lv, Wentao Mu, Yan‐Nan Cao, et al.
Journal of Hepatology (2025)
Open Access
Nephroprotective Effects of Selenium Nanoparticles Against Sodium Arsenite-Induced Damages
Shubin Li, Xingna Dong, Limeng Xu, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 3157-3176
Open Access | Times Cited: 10
Cisplatin-encapsulated TRAIL-engineered exosomes from human chorion-derived MSCs for targeted cervical cancer therapy
Miaomiao Ye, Tingxian Liu, Liqing Miao, et al.
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Therapeutic potential and protection enhancement of mesenchymal stem cell against cisplatin-induced nephrotoxicity using hyaluronic acid-chitosan nanoparticles as an adjuvant
Sarah Awwadh Altalhi, Ali A. Shati, Mohammad Y. Alfaifi, et al.
International Journal of Pharmaceutics (2023) Vol. 640, pp. 123023-123023
Closed Access | Times Cited: 8
Comparison of the ameliorative roles of crab chitosan nanoparticles and mesenchymal stem cells against cisplatin-triggered nephrotoxicity
Ali A. Shati, J. Alkabli, Mohammad Y. Alfaifi, et al.
International Journal of Biological Macromolecules (2023) Vol. 242, pp. 124985-124985
Closed Access | Times Cited: 7
Rheological, thermal and spectroscopical properties of the macromolecular complex between sodium hyaluronate and cisplatin for anticancer chemotherapy
Sabrina Banella, Abu T.M. Serajuddin, Gaia Colombo, et al.
Carbohydrate Polymer Technologies and Applications (2024) Vol. 7, pp. 100436-100436
Open Access | Times Cited: 2
LRG1 Contributes to the Pathogenesis of Multiple Kidney Diseases: A Comprehensive Review
Chunyan Chen, Jingwei Zhang, Tao Yu, et al.
Kidney Diseases (2024) Vol. 10, Iss. 3, pp. 237-248
Open Access | Times Cited: 2
Natural killer cells strengthen antitumor activity of cisplatin by immunomodulation and ameliorate cisplatin-induced side effects
Zhu Wang, Zhan Yang, Changbao Qu, et al.
International Urology and Nephrology (2023) Vol. 55, Iss. 8, pp. 1957-1970
Open Access | Times Cited: 4
The IDH1-R132H mutation aggravates cisplatin-induced acute kidney injury by promoting ferroptosis through disrupting NDUFA1 and FSP1 interaction
Kunmei Lai, Zhimin Chen, Siyi Lin, et al.
Cell Death and Differentiation (2024)
Open Access | Times Cited: 1
VALD‐2 mitigates cisplatin‐induced acute kidney injury: Mechanistic insights into oxidative stress modulation and inflammation suppression
Xuhui Zhao, Yuna Meng, Chunyan Dang, et al.
Journal of Biochemical and Molecular Toxicology (2024) Vol. 38, Iss. 8
Closed Access
Nephropathy induced by cisplatin results from mitochondrial disruption, impaired energy metabolism, altered expression of renal transporters, and accumulation of urinary toxins
Mingkang Zhang, Jianping Zhang, Yanrong Ma, et al.
Journal of Trace Elements in Medicine and Biology (2024) Vol. 86, pp. 127553-127553
Closed Access
Hyaluronic acid-coated Zein Nanoparticle-Mediated Resveratrol Therapy for the Reduction of Cisplatin-Associated Nephrotoxicity
Ning Yuan, Ping Chen, Zhengnan Shen, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 736, pp. 150873-150873
Closed Access
Necroptosis and autophagy in cisplatinum-triggered nephrotoxicity: Novel insights regarding their prognostic and diagnostic potential
Mai O. Kadry, Rehab M. Abdel‐Megeed
Toxicology Reports (2024) Vol. 13, pp. 101807-101807
Closed Access
Page 1

Scroll to top